Savara Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
/ 
Frequently asked questions
To buy Savara Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Savara Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Savara Inc. is SVRA:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Savara Inc. has its primary listing on NASDAQ (Small cap). You can trade Savara Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Savara Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Savara Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Savara Inc..